SYDNEY: In a major scientific breakthrough, a team of researchers in New South Wales has created the world’s first mRNA-based vaccine to combat foot-and-mouth disease (FMD), offering hope for stronger protection of livestock from this devastating virus. The vaccine, entirely synthetic, stands out for being safer and significantly faster to manufacture compared to traditional alternatives.
This landmark innovation is part of the Minns Government’s broader AU$1 billion biosecurity initiative to shield the region’s AU$8 billion livestock industry and strengthen national food security. Scientists have worked diligently over the past 18 months, investing AU$2.5 million in developing this groundbreaking solution.
The foot-and-mouth disease vaccine utilises cutting-edge mRNA technology, similar to that used in COVID-19 vaccines, allowing for a more rapid and adaptable response to emerging disease threats. With the livestock sector forming a vital part of Australia’s economy and food supply chain, this development has been hailed as a significant step forward.
Officials believe the introduction of this synthetic vaccine will help future-proof Australian livestock against major viral outbreaks, potentially sparing the industry from billions in losses. The government is now working closely with regulators to move towards commercial availability of the vaccine.
